hormone Archives - Good News!

IS MY CHILD’S GROWTH ON TRACK? What Parents Should Know September 14-20: Children’s Growth Awareness Week

Austin Tang — Wed, 17 Sep 2025 16:00:44 +0000

Listen to “IS MY CHILD’S GROWTH ON TRACK? What Parents Should Know September 14-20: Children’s Growth Awareness Week” on Spreaker.

Growth isn’t just about height—it’s a vital sign of a child’s overall health. Tracking physical growth is a crucial step towards monitoring your child’s health and an important factor in diagnosing pediatric growth hormone deficiency or PGHD.

PGHD is characterized by insufficient production of growth hormone (GH) by the pituitary gland, which is a small gland located at the base of the brain. It is estimated that 1 in 4,000-10,000 children globally have PGHD.

Here are 7 things children with PGHD may experience:

Short stature
Delayed puberty
Bone development challenges
Decreasing muscle mass and weakness
Emotional challenges
Low blood sugar
Reduced strength and endurance
Left untreated, PGHD can limit a child’s potential, physically, emotionally, and socially.

PGHD doesn’t just affect children—parents and caregivers of children with PGHD may feel discouraged and overwhelmed during this journey. Their concerns and fears about how this condition will impact their child can leave them feeling unheard.

It’s critical for parents to consult a healthcare professional as soon as they begin to notice delays in their child’s growth. Early diagnosis of PGHD and treatment are time-sensitive, especially because a child’s growth plates will eventually fuse, limiting their ability to achieve their full height potential. Delaying treatment can negatively impact final adult height and potentially affect other aspects of development.

For decades, the only treatment option available was daily injections of human growth hormone (somatropin). Long-acting growth hormone treatments have been developed that are given just once a week.

Healthcare professionals can work with parents to determine if treatment is needed and help ease concerns such as:

Noticing growth concerns and seeking guidance
Feeling anxious about timely diagnosis before growth plates fuse
Uncertainty about options to treat PGHD
Navigating the responsibilities of PGHD management
On Wednesday, September 17, Dr. Nidhi Gupta, pediatric endocrinologist, and founder and CEO of KAP Pediatric Endocrinology, is available to share her insights on what all parents need to know about PGHD. She will also discuss its signs and symptoms, and how treatment can help.

Interview courtesy: Ascendis Pharma

#AscendisPharma #GrowthAwarenessWeek #ChildsOverallHealth #PGHD #DiagnosingPediatricGrowthHormone

The post IS MY CHILD’S GROWTH ON TRACK? What Parents Should Know September 14-20: Children’s Growth Awareness Week appeared first on Good News!.

OSTEOPOROSIS CAUSES MORE THAN 8 MILLION FRACTURES WORLDWIDE ANNUALLY In Osteoporosis Patients A Fracture is Associated with an 86% Increased Risk of Future Fracture

Austin Tang — Thu, 24 Aug 2023 16:44:22 +0000

Listen to “OSTEOPOROSIS CAUSES MORE THAN 8 MILLION FRACTURES WORLDWIDE ANNUALLY In Osteoporosis Patients A Fracture is Associated with an 86%…” on Spreaker.

With an osteoporosis-related fracture occurring every three seconds worldwide – experts believe there’s an urgent need for women to understand their risk factors for the disease.3

UnderstandOP.com

Osteoporosis is a common disease among postmenopausal women and those who have it may suffer a fracture in their lifetime.4 Yet, the majority of those with osteoporosis do not know they have it. Often referred to as a “silent disease,” there are typically no symptoms of osteoporosis until a fracture occurs.5

Additionally, many postmenopausal women who have been diagnosed with osteoporosis do not fully understand the risks associated with it. A fracture is associated with serious consequences and can be a life altering event – and postmenopausal osteoporosis will get progressively worse if not treated.2,6 Meanwhile, research shows that many women decline treatment that can help reduce the risk of fracture.7

Osteoporosis is a chronic disease affecting 10 million U.S. adults.3,8 It occurs when an individual’s bone mineral density decreases, leading to a reduction in bone strength which can increase the risk of fractures, or broken bones.5 This is especially common in women because hormone changes associated with menopause can lead to a rapid reduction in bone density – putting them at risk for fracture.4

Kristi Tough DeSapri, M.D.— owner of Bone & Body Women’s Health, a midlife women’s health medical practice — will discuss the need for women to understand their risk factors for osteoporosis and find strategies to maintain bone strength and reduce the risk for falls and fractures.

Dr. Tough DeSapri will discuss the risk factors for osteoporosis as well as explain why, after menopause, women should take an osteoporosis diagnosis seriously – and how they can be proactive in reducing their risk of fractures.

Courtesy: Amgen

#drkristitoughdesapri #menopause #osteoporosis #patients #futurefracture #risk #disease

The post OSTEOPOROSIS CAUSES MORE THAN 8 MILLION FRACTURES WORLDWIDE ANNUALLY In Osteoporosis Patients A Fracture is Associated with an 86% Increased Risk of Future Fracture appeared first on Good News!.

October is Breast Cancer Awareness Month NEW STUDY CONFIRMS EVEN MORE WOMEN WITH BREAST CANCER CAN SKIP CHEMOTHERAPY

Austin Tang — Mon, 18 Oct 2021 22:52:12 +0000

Listen to “October is Breast Cancer Awareness Month NEW STUDY CONFIRMS EVEN MORE WOMEN WITH BREAST CANCER CAN SKIP CHEMOTHERAPY” on Spreaker.

New research expands the number of women with a common type of early stage breast cancer who can skip chemotherapy and safely be treated with hormone-blocking therapies alone – even if their cancer has spread to some of their lymph nodes.[1] However, women whose tumors have spread to their lymph nodes are often at higher risk of worse outcomes, with the majority receiving chemotherapy.[2] Results from the RxPONDER study, one of the largest clinical trials in hormone receptor-positive, HER2 negative early breast cancer, were presented at the San Antonio Breast Cancer Symposium in late 2020.1
Based on these new findings, postmenopausal women whose cancer has spread to between one and three lymph nodes can avoid the side effects associated with chemotherapy if their Oncotype DX Breast Recurrence Score® result, a genomic test which predicts chemotherapy benefit and risk of cancer recurrence, is between 0 and 25.1
Breast cancer is the most commonly diagnosed cancer worldwide, surpassing lung cancer for the first time in 2020.[3] With the growing recognition of the importance of personalized treatment for breast cancer, genomic testing can help tailor treatment decisions to a patient’s individual tumor. Facing a breast cancer diagnosis can be overwhelming but getting a genomic test to understand the unique biology of a patient’s tumor can help guide personalized treatment decisions.
Our guest, Dr. Deepa Halaharvi, a board-certified breast cancer surgeon at Ohio Health, can speak to the practice-changing impact of this recent study for postmenopausal women with node-positive breast cancer and the importance of genomic tests in enabling confident breast cancer treatment decisions.
As a breast cancer survivor herself, Dr. Halaharvi is in the unique position of seeing breast cancer from the perspective of a doctor as well as a patient. She will share her cancer story, including how the Oncotype DX® test informed her treatment, following her diagnosis with stage 1 HR positive, HER2 negative breast cancer at age 42, just 8 months after becoming a practicing breast surgeon. She’ll also talk about how her personal experience has greatly impacted the type of care she offers her patients, helping them to survive and thrive.
Interview sponsored by Exact Sciences Corporation

#deepa #halaharvi #breast #cancer #chemotherapy #therapies #hormone #blocking #lymph #nodes #rxponder #menopausal #effects #oncotype #dx #recurrence #genomic #benefit #risk #exact

The post October is Breast Cancer Awareness Month NEW STUDY CONFIRMS EVEN MORE WOMEN WITH BREAST CANCER CAN SKIP CHEMOTHERAPY appeared first on Good News!.

Queens “Walk for Kids Growth” to Increase Awareness

admin — Mon, 17 Mar 2014 18:44:48 +0000

Queens “Walk for Kids Growth” to Increase Awareness

of Large Number of Children with Growth Hormone Deficiency

WHO:

Patti Costa, executive director, Human Growth Foundation

WHAT:

Research shows 48% of children with growth disorders have gone undiagnosed. The Walk for Kids Growth community-wide event, hosted by nonprofit Human Growth Foundation, will increase awareness of childhood growth disorders, growth hormone deficiency and the importance of early diagnosis and treatment. Walk for Kids Growth will feature a scenic 3-mile fun walk, live musical entertainment by local teen band Before the Anchors, refreshments, display/educational booths, and giveaways.

WHEN:

Sunday, April 6, 2014

1 pm

Flushing Meadows Corona Park, (at Fountain of the Planets)

Queens, NY 11367

TALKING POINTS:

What is growth hormone deficiency?

How does growth hormone deficiency effect children?

Walk for Kids Growth will increase awareness of childhood growth disorders, growth hormone deficiency, early diagnosis and treatment.

Funds raised through Walk for Kids Growth will help provide research, education, patient support, and advocacy.

Visit: http://www.stepupandwalkforhgf.org/

The post Queens “Walk for Kids Growth” to Increase Awareness appeared first on Good News!.